Qiagen NV

QGEN NYSE Healthcare & Biotech Monde NL0012169213
36.78 $
2.06 %

Qiagen NV specializes in providing and products for molecular diagnostics and life sciences research.

Price history of Qiagen NV
Price history of Qiagen NV

Performance & Momentum

6 Months 21.75 %
1 Year 18.84 %
3 Years 19.54 %
5 Years 22.83 %

Strategic Analysis

Qiagen NV • 2026

Qiagen is a global specialist in molecular diagnostics and laboratory , with a business model built on the recurring sale of kits, consumables, and analytical instruments. Its positioning relies on strong scientific expertise and a diversified customer base across healthcare, research, and life sciences, giving it a defensive, technology-driven niche.

Strengths
  • Recognized expertise in molecular diagnostics and laboratory analytical solutions
  • Business model combining instruments and consumables, supporting a recurring revenue stream
  • Global footprint and exposure to multiple end markets in healthcare and research
Weaknesses
  • Stock and operating growth have recently come under pressure, with a weakened market trend
  • Sensitive to spending cycles in laboratories, hospitals, and research budgets
Momentum

Momentum appears moderately positive on a signal basis, but remains clearly improving on a relative basis within an equity history that is still weak. Recent trends suggest the beginning of stabilization after a prolonged period of underperformance, without confirming a true structural turnaround at this stage. For investors, this points to a potential recovery profile, but one that still requires clearer evidence of renewed growth and rerating.

Similar stocks to Qiagen NV

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone